Search
Following a review of available evidence, WHO’s International Agency for Research on Cancer has issued a perspective on the use of various screening methods for the prevention of colorectal cancer.
A 14-year-old African American boy presented during the winter months with a painless, nonpruritic, periumbilical rash that had been present for approximately 1 month.
<p>Young children are more likely to get hurt when they are not fully supervised by adults, and especially when they are out of arm's reach, a new study suggests.</p><p> </p>
In this podcast, Jonathan Aviv, MD, talks about the current gold standards for treating gastroesophageal reflux disease, where proton-pump inhibitor therapy fits into the treatment regimen, and nonpharmacologic treatment options.
In this video, Margo Minissian, PhD, ACNP, speaks about cholesterol management guidelines, including managing patients with statin myalgia and patients at risk for polypharmacy, and strategies for LDL lowering therapies. She also spoke about this topic at our Practical Updates in Primary Care 2021 virtual series.
<p>Children with an autism spectrum disorder were more likely to have mothers who lived close to fields treated with certain pesticides during pregnancy.</p>
<p style="text-align: left;"><span>A new study documents the effect of waning immunity on a population level.</span></p>
In a recent study, researchers examined the global prevalence and factors associated with glaucoma-related blindness and vision loss.
In this video, Jonathan A. Bernstein, MD, explains the results of a study that focused on efficacy of biologics in patients with severe allergic asthma, including omalizumab, belimumab, mepolizumab, dupilumab, and tezepelumab. Dr Bernstein also spoke about these topics during his session titled “Efficacy of Biologics in Patients With Severe Asthma, Overall and by Blood Eosinophil Count” at ACAAI Annual Scientific Meeting.
<P><IMG style="MARGIN: 5px; FLOAT: left" src="/sites/default/files/transfer/1206CFP_ECKamat_BioPic.jpg" width=90 height=90> Deepak M. Kamat, MD, PhD, professor of pediatrics and longtime <EM>Consultant For Pediatricians</EM> Editorial Board member, was recognized by Wayne State University with the 2012 President’s Award for Excellence in Teaching. The faculty members who receive this award have made outstanding contributions in their field of education and demonstrate exceptional knowledge, unwavering enthusiasm, and an uncanny ability to motivate students. </P>
The first participant of the Phase 1 clinical trial has received the investigational vaccine for COVID-19. US researchers will be analyzing the vaccine’s safety and effectiveness.
By Megan BrooksNEW YORK (Reuters Health) - One or two doses of the diphtheria-tetanus-acellular pertussis (DTaP) vaccine provides good protection against pertussis in the first year of life, new research from Australia shows.However, researchers also found the effectiveness of three doses wanes quickly in preschoolers without a booster dose.
New research from the World Health Organization examined the risks associated with consumption of red and processed meats.
By Lisa Rapaport
(Reuters Health) - A recent research review finds that sugar substitutes may not promote eating more calories or packing on extra pounds.
The existing body of research on artificial sweeteners is a bit of a mixed bag. Some studies have linked sugar substitutes - especially in diet drinks - to increased appetite or changes in the way the body handles sugar. But other research has tied the products to successful weight loss.
Researcher’s have a new insight into how the TB pathogen evades the immune system after the largest study of tuberculosis susceptibility.
The definition comprises 3 criteria: treatment failure history, characterization of active/symptomatic disease, and clinical perception.
Researchers tested the effects of a common herpes medication on levels of HIV-1 in patients with and without herpes infection.
Researchers revisit data from the pivotal ARISTOTLE trial of 2011, uncovering new significant findings involving the control of hypertension in patients with atrial fibrillation.
Researchers released preliminary findings on the effects of a promising new treatment that could help to “reboot” the immune system.